Wird geladen...
Evaluating the Use of Octreotide for Acquired Chylothorax in Pediatric Critically Ill Patients Following Cardiac Surgery
OBJECTIVES: To evaluate the impact of octreotide on time to resolution of chylothorax compared with conventional therapy. Secondary outcomes include the following: time to reduction of chest tube output by 20%, additional surgeries for chylothorax, hospital length of stay, in-hospital mortality, and...
Gespeichert in:
| Veröffentlicht in: | J Pediatr Pharmacol Ther |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Pediatric Pharmacy Advocacy Group
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6782119/ https://ncbi.nlm.nih.gov/pubmed/31598104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-24.5.406 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|